Evidence map›Paper›PMID 26452764›Full record

ArticleFolia microbiologica2016

Molecular characterization of bacteremic Escherichia coli isolates in Romania.

Codruţa-Romaniţa Usein, Raluca Papagheorghe, Mihaela Oprea, Maria Condei, Monica Strãuţ

Abstract read
PubMed Publisher
In one paragraph

Article in Folia microbiologica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Antimicrobial agents and chemotherapy · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. TEM,CTX-M,SHV Genes in ESBL-ProducingAntibiotics (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Genomic Analysis of ESBL-ProducingAntibiotics (Basel, Switzerland) · 2022
    Article
  10. Faecal carriage of ESBL producing and colistin resistantFrontiers in cellular and infection microbiology · 2022
    Article
  11. Animals : an open access journal from MDPI · 2020
    Review
  12. Article
  13. Frontiers in cellular and infection microbiology · 2019
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Codruţa-Romaniţa UseinCantacuzino National Institute of Research-Development for Microbiology and Immunology, Splaiul Independentei 103, sector 5, 050096, Bucharest, Romania. rusein@cantacuzino.ro.
Raluca PapagheorgheColţea Clinical Hospital, Bulevardul I.C.Bratianu 1, sector 3, Bucharest, Romania.
Mihaela OpreaCantacuzino National Institute of Research-Development for Microbiology and Immunology, Splaiul Independentei 103, sector 5, 050096, Bucharest, Romania.
Maria CondeiCantacuzino National Institute of Research-Development for Microbiology and Immunology, Splaiul Independentei 103, sector 5, 050096, Bucharest, Romania.
Monica StrãuţCantacuzino National Institute of Research-Development for Microbiology and Immunology, Splaiul Independentei 103, sector 5, 050096, Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prevalence of invasive infections caused by antibiotic resistant Escherichia coli strains in Romanian patients, already mentioned in the European reports, requires better knowledge of their specific traits. Thus, a set of 38 E. coli blood isolates, collected between 2010 and 2012 at one of the local hospitals participating into the European Antimicrobial Resistance Surveillance Network, was investigated retrospectively with respect to the phylogenetic origin, extraintestinal virulence-associated markers (i.e. fimH, papC, papG alleles, sfa/foc, afa/dra, hly, cnf1, sat, iucC, fyuA, ibeA), and beta-lactamase encoding genes (i.e. bla CTX-M, bla TEM, and bla SHV alleles). The isolates with extended-spectrum beta-lactamase (ESBL) phenotypes were further characterized using PCR-based replicon typing and multilocus sequencing typing. For ST131 members, pulsed-field gel electrophoresis (PFGE) and PCR-based detection of fimH30 allele were performed. Overall, the isolates were more likely members of the major phylogenetic group A (53 %) and to a lesser extent of groups B2 (29 %), D (10 %), and B1 (8 %). All but three of the virulence markers sought (i.e. papGI, hly, cnf1) were detected with prevalence ranging from 3 % (i.e. ibeA, papGIII) to 87 % (fimH). As expected, the most complex genotypes (four to seven virulence markers) defined the isolates derived from phylogenetic groups B2 and D. ESBL producers were bla CTX-M-15-positive, mostly of phylogroup A (67 %), harboured IncF multireplicon plasmids, and belonged to six sequence types (i.e. ST10, ST131, ST167, ST410, ST540, ST1275). Members of ST10 clonal complex (i.e. ST10, ST167) were the most common. The ST131 isolates belonged to H30 subclone and displayed 74 % similarity at PFGE analysis.

Indexed as

BacteremiaMolecular TypingAnti-Bacterial Agentsbeta-LactamasesEscherichia coliEscherichia coli InfectionsGenotypeHumansMicrobial Sensitivity TestsMultilocus Sequence TypingPhylogenyRomaniaVirulence FactorsAnti-Bacterial Agentsbeta-LactamasesVirulence Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.